Esketamine
Back to searchMolecule Structure
Scientific Name
Esketamine
Description of the Drug
Esketamine is a NMDA receptor antagonist used for treatment-resistant depression.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11823
http://www.drugbank.ca/drugs/DB11823
Brand Name(s)
Not Available
Company Owner(s)
Janssen Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glutamate [NMDA] receptor | PROTEIN COMPLEX GROUP | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL2094124 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5512024 | |||
| DrugBank | DB11823 | |||
| PubChem: Thomson Pharma | 14798299 | |||
| PubChem | 182137 | |||
| Nikkaji | J238.630E | |||
| PDBe | JC9 | |||
| EPA CompTox Dashboard | DTXSID6047810 | |||
| DrugCentral | 4468 | |||
| Guide to Pharmacology | 9152 | |||
| rxnorm | ESKETAMINE HYDROCHLORIDE | SPRAVATO | ESKETAMINE | KETAVED |
| ChEBI | 60799 | |||
| ZINC | ZINC000035999642 |
